During the past 10 years, overall outsourcing has grown 13.3 percent per year, outpacing a 9 percent annual growth of total R&D spending. In Europe, Frost & Sullivan estimates the contract research organization (CRO) market will grow at an annual rate of 9.6 percent between 2011 and 2018. Read More
The pace of the industry's mergers and acquisitions (M&A's) activity is a closely tracked statistic. The number of deals conducted each year not only reflects the vibrancy of the sector but also speaks to the business strategies of pharmaceutical companies. The common trend over the past five years or so has been for pharma firms to boost their thinning product pipelines by acquiring biotech's own innovation. Read More